Growth factor delivery-based tissue engineering: general approaches and a review of recent developments
暂无分享,去创建一个
[1] Hyun Chul Lee,et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.
[2] Tao L Lowe,et al. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. , 2008, Biomaterials.
[3] W. Sebald,et al. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.
[4] Charles Tator,et al. Novel intrathecal delivery system for treatment of spinal cord injury , 2003, Experimental Neurology.
[5] M. Fussenegger,et al. Drug-sensing hydrogels for the inducible release of biopharmaceuticals. , 2008, Nature materials.
[6] J. Isner,et al. Therapeutic Angiogenesis for Coronary Artery Disease , 2002, Annals of Internal Medicine.
[7] J L West,et al. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. , 2001, Biomaterials.
[8] Charles Tator,et al. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. , 2009, Tissue engineering. Part A.
[9] David J Mooney,et al. Regulating myoblast phenotype through controlled gel stiffness and degradation. , 2007, Tissue engineering.
[10] Rui L Reis,et al. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. , 2009, Biomacromolecules.
[11] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[12] B. Amsden,et al. Combined and sequential delivery of bioactive VEGF165 and HGF from poly(trimethylene carbonate) based photo-cross-linked elastomers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[13] Masashi Komeda,et al. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. , 2005, Journal of vascular surgery.
[14] Toshiyuki Kanamori,et al. Reversible and Efficient Proton Dissociation of Spirobenzopyran-Functionalized Poly(N-isopropylacrylamide) in Aqueous Solution Triggered by Light Irradiation and Temporary Temperature Rise , 2004 .
[15] P. Ascenzi,et al. Preparation and characterization of pH- and temperature-sensitive pullulan microspheres for controlled release of drugs. , 2008, Biomaterials.
[16] Tomoyuki Ishikawa,et al. Rapid and reversible shape changes of molecular crystals on photoirradiation , 2007, Nature.
[17] J. Hubbell,et al. Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] J. Huot,et al. Endothelial cell migration during angiogenesis. , 2007, Circulation research.
[19] You Han Bae,et al. Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.
[20] Yoshihiro Ito,et al. Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.
[21] David J. Mooney,et al. Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.
[22] Y. Ikada,et al. Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release , 1999 .
[23] Kristi S Anseth,et al. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. , 2009, Biomaterials.
[24] P. Janmey,et al. Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.
[25] L. Schmidt‐Mende,et al. ZnO - nanostructures, defects, and devices , 2007 .
[26] Charles H Tator,et al. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. , 2006, Biomaterials.
[27] Peter X Ma,et al. Surface modification of interconnected porous scaffolds. , 2005, Journal of biomedical materials research. Part A.
[28] Rui L. Reis,et al. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. , 2009, Biomaterials.
[29] Soong Ho Um,et al. Enzyme-catalysed assembly of DNA hydrogel , 2006, Nature materials.
[30] R. A. Jain,et al. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.
[31] L. Orci,et al. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.
[32] P. M. Welch. A tunable dendritic molecular actuator. , 2005, Nano letters.
[33] J. Ware,et al. Therapeutic angiogenesis in cardiovascular disease , 2003, Nature Reviews Drug Discovery.
[34] A. Domb,et al. Chemical Interactions Between Drugs Containing Reactive Amines with Hydrolyzable Insoluble Biopolymers in Aqueous Solutions , 1994, Pharmaceutical Research.
[35] S. Ashley,et al. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. , 2008, Biomaterials.
[36] F. Siccardi. Considerations concerning the host-parasite relationship of Escherichia coli in poultry. , 1975, American journal of veterinary research.
[37] J. Hubbell,et al. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. , 2004, Microvascular research.
[38] M. Shoichet,et al. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. , 2004, Journal of biomedical materials research. Part A.
[39] V. Hasırcı,et al. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.
[40] F. Krause,et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. , 2008, The Journal of bone and joint surgery. American volume.
[41] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[42] Ralph Müller,et al. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. , 2006, Biomacromolecules.
[43] Philip R. Kuhl,et al. Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.
[44] Michiya Matsusaki,et al. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering. , 2005, Biomacromolecules.
[45] Brian H Annex,et al. A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans , 2002, Clinical pharmacology and therapeutics.
[46] J. Hubbell,et al. Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[47] Robert E Guldberg,et al. Sustained release of BMP-2 in a lipid-based microtube vehicle. , 2009, Acta biomaterialia.
[48] Robert Langer,et al. Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .
[49] Antonios G. Mikos,et al. Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications , 2005 .
[50] T. Henry,et al. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.
[51] Koichi Masuda,et al. Chapter 62: TISSUE ENGINEERING FOR REGENERATION AND REPLACEMENT OF THE INTERVERTEBRAL DISC , 2006 .
[52] Antonios G Mikos,et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.
[53] Peter Carmeliet,et al. Angiogenesis in life, disease and medicine , 2005, Nature.
[54] Doo Sung Lee,et al. Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid--liquid phase separation of a PLLA--dioxane--water system. , 2002, Journal of biomedical materials research.
[55] Sung Wan Kim,et al. Sulfonamide-based pH- and temperature-sensitive biodegradable block copolymer hydrogels. , 2006, Biomacromolecules.
[56] J. Hubbell,et al. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. , 2005, Biophysical journal.
[57] G. Tucker. Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.
[58] K. Anseth,et al. Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[59] Yong Wang,et al. Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release. , 2010, Chemical communications.
[60] D. Wise,et al. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. , 1997, Journal of biomedical materials research.
[61] Takashi Miyata,et al. A reversibly antigen-responsive hydrogel , 1999, Nature.
[62] D. Mooney,et al. Regulating activation of transplanted cells controls tissue regeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[63] Wenjun Guo,et al. Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.
[64] Giovanna Pitarresi,et al. Biodegradable and pH-sensitive hydrogels for potential colon-specific drug delivery: characterization and in vitro release studies. , 2008, Biomacromolecules.
[65] Krishnendu Roy,et al. Biomaterials for stem cell differentiation. , 2008, Advanced drug delivery reviews.
[66] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[67] S. Guelcher,et al. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. , 2009, Biomaterials.
[68] VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.
[69] J. Hubbell,et al. Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. , 2005, Acta biomaterialia.
[70] Eben Alsberg,et al. Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue Engineering , 2001, Biotechnology progress.
[71] J. Hubbell,et al. Bioactive biomaterials. , 1999, Current opinion in biotechnology.
[72] Mark C Manning,et al. The stability factor: importance in formulation development. , 2002, Current pharmaceutical biotechnology.
[73] J. Isner,et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. , 1994, Circulation.
[74] J. Hubbell,et al. Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[75] Shigeru Deguchi,et al. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles , 1993 .
[76] M. Shive,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .
[77] H. Chung,et al. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor. , 2007, Journal of biomedical materials research. Part A.
[78] J. Fisher,et al. Thermoreversible hydrogel scaffolds for articular cartilage engineering. , 2004, Journal of biomedical materials research. Part A.
[79] Daniel G. Anderson,et al. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[80] D J Mooney,et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[81] Y. Uchida,et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.
[82] G. McConnell,et al. Enzyme responsive polymer hydrogel beads. , 2005, Chemical communications.
[83] Robert Langer,et al. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. , 2006, Biomaterials.
[84] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[85] M. Fehlings,et al. The Safety and Efficacy of OP-1 (rhBMP-7) as a Replacement for Iliac Crest Autograft in Posterolateral Lumbar Arthrodesis: A Long-term (>4 Years) Pivotal Study , 2008, Spine.
[86] N. Cameron,et al. Emulsion-Derived Foams (PolyHIPEs) Containing Poly(ε-caprolactone) as Matrixes for Tissue Engineering , 2001 .
[87] P. Kligfield,et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. , 1999, Annals of surgery.
[88] David J. Mooney,et al. Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.
[89] Fa-Ming Chen,et al. In vitro cellular responses to scaffolds containing two microencapulated growth factors. , 2009, Biomaterials.
[90] Dean-Mo Liu,et al. Magnetic-sensitive silica nanospheres for controlled drug release. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[91] Jae Sun Yoo,et al. Novel injectable pH and temperature sensitive block copolymer hydrogel. , 2005, Biomacromolecules.
[92] Mizuo Maeda,et al. DNA-responsive hydrogels that can shrink or swell. , 2005, Biomacromolecules.
[93] K. Akiyoshi,et al. Thermoresponsive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: heat shock protein-like activity of artificial molecular chaperone. , 2005, Biomacromolecules.
[94] N. Cameron,et al. Emulsion-derived foams (PolyHIPEs) containing poly(epsilon-caprolactone) as matrixes for tissue engineering. , 2001, Biomacromolecules.
[95] J. Hubbell,et al. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. , 2007, The Journal of thoracic and cardiovascular surgery.
[96] Kristi S. Anseth,et al. Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties , 2009, Science.
[97] David J Mooney,et al. Protein-based signaling systems in tissue engineering. , 2003, Current opinion in biotechnology.
[98] Chi‐Hwa Wang,et al. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. , 2009, Journal of biomedical materials research. Part A.
[99] A. Maruyama,et al. Thermosensitive transparent semi-interpenetrating polymer networks for wound dressing and cell adhesion control. , 2008, Biomacromolecules.
[100] Daniel Scherman,et al. Growth factor delivery approaches in hydrogels. , 2009, Biomacromolecules.
[101] Robert Langer,et al. Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.
[102] Charles Tator,et al. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord , 2005, Experimental Neurology.
[103] T. Sheffield,et al. Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. , 2004, Biomacromolecules.
[104] R. K. Evans,et al. Analysis of plasmid DNA from a pharmaceutical perspective. , 1998, Journal of pharmaceutical sciences.
[105] David J Mooney,et al. Integrated approach to designing growth factor delivery systems , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[106] Antonios G Mikos,et al. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[107] J. Hubbell,et al. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.
[108] Antonios G Mikos,et al. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. , 2005, Biomaterials.
[109] E. Smela,et al. Microfabricating conjugated polymer actuators. , 2000, Science.
[110] Jennifer L. West,et al. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .
[111] D. Baltimore,et al. Modular binding domains in signal transduction proteins , 1995, Cell.
[112] Jörg A Auer,et al. Localized insulin-like growth factor I delivery to enhance new bone formation. , 2003, Bone.
[113] Michael Cross,et al. Growth factors in development, transformation, and tumorigenesis , 1991, Cell.
[114] D. Puleo,et al. In vitro effects of combined and sequential delivery of two bone growth factors. , 2004, Biomaterials.
[115] A A Poot,et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.
[116] R Langer,et al. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.
[117] David J. Mooney,et al. Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.
[118] K. Leong,et al. Fabrication of controlled release biodegradable foams by phase separation. , 1995, Tissue engineering.
[119] Taizo Shiraishi,et al. Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel , 2008, Cancer science.
[120] Micheline Piquette-Miller,et al. Biocompatibility of injectable chitosan-phospholipid implant systems. , 2009, Biomaterials.
[121] Vasif Hasirci,et al. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. , 2008, Biomaterials.
[122] Brian H Annex,et al. The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003 .
[123] Franz E Weber,et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.
[124] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[125] Yuquan Wei,et al. Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity , 2009, Growth factors.
[126] Eben Alsberg,et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.
[127] S. Mirza,et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. , 2006, The Journal of bone and joint surgery. American volume.
[128] Siccardi Fj. Considerations concerning the host-parasite relationship of Escherichia coli in poultry. , 1975 .
[129] M. Madou,et al. Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics , 2005, Nature Materials.
[130] J M Powers,et al. Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. , 1995, Journal of biomaterials science. Polymer edition.
[131] F. Isik,et al. Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells , 2001, Molecular and Cellular Biochemistry.
[132] S. Bhatia,et al. Protease-triggered unveiling of bioactive nanoparticles. , 2008, Small.
[133] Gordon L. Amidon,et al. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.
[134] J. Isner,et al. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. , 1994, The American journal of physiology.
[135] D. S. Lee,et al. Functionalized injectable hydrogels for controlled insulin delivery. , 2008, Biomaterials.
[136] J. Hubbell,et al. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.
[137] David J Mooney,et al. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.
[138] E. Kang,et al. Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering. , 2009, Tissue engineering. Part A.
[139] Jordi Casanovas,et al. Conducting polymer actuator mechanism based on the conformational flexibility of calix[4]arene. , 2006, Angewandte Chemie.
[140] David J Mooney,et al. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. , 2007, Advanced drug delivery reviews.
[141] Parkson Lee-Gau Chong,et al. Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[142] B. V. von Specht,et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.
[143] Antonios G Mikos,et al. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[144] David J. Mooney,et al. Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.
[145] W. Sebald,et al. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. , 1999, Journal of molecular biology.
[146] Kevin E. Healy,et al. A novel method to fabricate bioabsorbable scaffolds , 1995 .
[147] Matthias P Lutolf,et al. Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. , 2007, Biomaterials.
[148] J. Hubbell,et al. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[149] Dustin J. Maxwell,et al. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. , 2007, Journal of biomedical materials research. Part A.
[150] Smadar Cohen,et al. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.
[151] Martin Ehrbar,et al. Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[152] David Putnam,et al. Polymers for gene delivery across length scales , 2006, Nature materials.
[153] Vesselin Shanov,et al. A multi-wall carbon nanotube tower electrochemical actuator. , 2006, Nano letters.
[154] Kristi S Anseth,et al. Controlling Affinity Binding with Peptide‐Functionalized Poly(ethylene glycol) Hydrogels , 2009, Advanced functional materials.
[155] A. Sieron,et al. Site-specific interaction of bone morphogenetic protein 2 with procollagen II. , 2002, Cytokine.
[156] R. Zhuo,et al. Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release. , 2008, Biomacromolecules.
[157] J. Vacanti,et al. Transplantation of hepatocytes using porous, biodegradable sponges. , 1994, Transplantation proceedings.
[158] Antonios G Mikos,et al. Thermoresponsive hydrogels in biomedical applications. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[159] David J. Mooney,et al. Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.
[160] Ralph Weissleder,et al. In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.
[161] Lorenz Meinel,et al. Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. , 2009, Biomaterials.
[162] A. Metters,et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[163] R. Langer,et al. Light-induced shape-memory polymers , 2005, Nature.
[164] Smadar Cohen,et al. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. , 2009, Biomaterials.
[165] J. Schalkwijk,et al. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. , 2007, Biomaterials.
[166] J. Pearlman,et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. , 1999, Circulation.
[167] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[168] J. Benoit,et al. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. , 2003, Biomaterials.
[169] T. Albert,et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. , 2008, The spine journal : official journal of the North American Spine Society.
[170] H. Ohgushi,et al. Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells. , 2002, Journal of biomedical materials research.
[171] David A. Cheresh,et al. Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis , 2003, The Journal of cell biology.
[172] D. Mooney,et al. Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. , 2009, Biomaterials.
[173] Ralph Müller,et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.
[174] J. Ware,et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. , 2002, The Journal of thoracic and cardiovascular surgery.
[175] S J Bryant,et al. The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels. , 2001, Biomaterials.
[176] Antonios G Mikos,et al. Biomimetic materials for tissue engineering. , 2003, Biomaterials.
[177] R. Langer,et al. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. , 1994, Biomaterials.
[178] D. Mooney,et al. Hydrogels for tissue engineering. , 2001, Chemical Reviews.
[179] A. Asthagiri,et al. Tunable interplay between epidermal growth factor and cell–cell contact governs the spatial dynamics of epithelial growth , 2009, Proceedings of the National Academy of Sciences.
[180] D. Mooney,et al. Polymers for pro- and anti-angiogenic therapy. , 2007, Biomaterials.
[181] Samir Mitragotri,et al. Physical approaches to biomaterial design. , 2009, Nature materials.
[182] M. Noda,et al. Nanogel‐based delivery system enhances PGE2 effects on bone formation , 2007, Journal of cellular biochemistry.
[183] You Han Bae,et al. Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[184] D J Mooney,et al. Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.
[185] Y. Iwasaki,et al. Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: interaction with proteins and chaperone-like activity. , 2005, Biomacromolecules.
[186] Martin Ehrbar,et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[187] L. Meinel,et al. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[188] Anna Gutowska,et al. Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. , 2002, Biomacromolecules.
[189] Jeffrey A. Hubbell,et al. Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth , 2004, Circulation research.
[190] D. Rifkin,et al. Cell signaling events: a view from the matrix. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[191] E. Brogi,et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.
[192] A. Mikos,et al. Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers. , 2008, Biomacromolecules.
[193] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[194] R. Eavey,et al. Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold , 2000, The Laryngoscope.
[195] Jiehyun Seong,et al. New thermogelling poly(organophosphazenes) with methoxypoly(ethylene glycol) and oligopeptide as side groups , 2005 .
[196] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[197] Jean M. J. Fréchet,et al. A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[198] Eun-Suk Kim,et al. Material-based deployment enhances efficacy of endothelial progenitor cells , 2008, Proceedings of the National Academy of Sciences.
[199] David J Mooney,et al. Synthetic extracellular matrices for tissue engineering and regeneration. , 2004, Current topics in developmental biology.
[200] J. Hubbell,et al. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 , 2004 .
[201] Sérgio Simões,et al. On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.
[202] N. Ortéga,et al. Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[203] Richard T. Lee,et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.